Zofenopril Plus Hydrochlorothiazide and Irbesartan Plus Hydrochlorothiazide in Previously Treated and Uncontrolled Diabetic and Non-diabetic Essential Hypertensive Patients

Enrico Agabiti-Rosei, Athanasios Manolis, Dario Zava, Stefano Omboni
  • Advances in Therapy, January 2014, Springer Science + Business Media
  • DOI: 10.1007/s12325-013-0090-8

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1007/s12325-013-0090-8

The following have contributed to this page: Prof. Stefano Omboni